FARNWORTH FAMILY PRACTICE — All Prescriptions & Medications
Practice Code: P82652 | BOLTON, BL4 9AH
Over the last 12 months, FARNWORTH FAMILY PRACTICE prescribed 92,353 items across 425 different medications at a total cost of £596,372 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Budesonide | 10 | 336 | £694 | -36.2% ▼ |
| Dabigatran etexilate | 10 | 600 | £489 | -80.7% ▼ |
| Indacaterol/glycopyrronium | 10 | 300 | £309 | -77.9% ▼ |
| Galantamine | 10 | 280 | £227 | -73.6% ▼ |
| Ivermectin | 10 | 77 | £1.0K | +2.5% ▲ |
| Cabergoline | 10 | 80 | £253 | -35.5% ▼ |
| Water for injection | 10 | 120 | £38 | -70.4% ▼ |
| Adapalene | 10 | 900 | £312 | -54.3% ▼ |
| Bempedoic acid/Ezetimibe | 11 | 308 | £579 | -82.0% ▼ |
| Ethosuximide | 11 | 616 | £1.1K | -25.4% ▼ |
| Rasagiline mesilate | 11 | 308 | £216 | -70.4% ▼ |
| Magnesium aspartate | 11 | 282 | £254 | -27.4% ▼ |
| Pyridoxine hydrochloride | 11 | 700 | £309 | -48.8% ▼ |
| Powder micronutrient supplement (0913291) | 11 | 8,800 | £1.1K | +38.4% ▲ |
| Carbomer 940/980 | 11 | 810 | £124 | -92.8% ▼ |
| Hyoscine hydrobromide | 11 | 75 | £255 | -13.2% ▼ |
| 11 | 880 | £475 | -20.6% ▼ | |
| 11 | 660 | £233 | +56.7% ▲ | |
| Prucalopride | 12 | 336 | £125 | -69.2% ▼ |
| Desloratadine | 12 | 824 | £91 | -58.4% ▼ |
| Amisulpride | 12 | 672 | £92 | -82.9% ▼ |
| Levomepromazine hydrochloride | 12 | 80 | £154 | -47.9% ▼ |
| Primidone | 12 | 336 | £512 | -66.3% ▼ |
| Erythromycin | 12 | 364 | £178 | -65.4% ▼ |
| Insulin Lispro | 12 | 35 | £208 | -84.3% ▼ |
| Etodolac | 12 | 336 | £166 | -56.7% ▼ |
| Acetazolamide | 12 | 672 | £27 | -44.6% ▼ |
| 12 | 1,500 | £14 | -52.3% ▼ | |
| 12 | 60 | £188 | -50.4% ▼ | |
| 12 | 1,200 | £247 | -56.1% ▼ | |
| 12 | 1,950 | £193 | -75.1% ▼ | |
| 12 | 2,520 | £179 | +12.8% ▲ | |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 13 | 364 | £168 | -20.5% ▼ |
| Hydralazine hydrochloride | 13 | 364 | £20 | -69.2% ▼ |
| Moxonidine | 13 | 364 | £43 | -76.6% ▼ |
| Naftidrofuryl oxalate | 13 | 1,092 | £128 | -60.1% ▼ |
| Omega-3-acid ethyl esters | 13 | 1,120 | £541 | -38.5% ▼ |
| Colestyramine | 13 | 364 | £82 | -54.9% ▼ |
| Lofepramine hydrochloride | 13 | 364 | £157 | -56.5% ▼ |
| Lacosamide | 13 | 728 | £1.9K | -75.8% ▼ |
| Eslicarbazepine acetate | 13 | 546 | £2.4K | -41.7% ▼ |
| Aciclovir | 13 | 486 | £32 | -91.3% ▼ |
| Insulin degludec | 13 | 47 | £439 | -88.2% ▼ |
| Dulaglutide | 13 | 60 | £1.1K | -88.7% ▼ |
| Raloxifene hydrochloride | 13 | 364 | £52 | -12.0% ▼ |
| Progesterone | 13 | 495 | £104 | -96.9% ▼ |
| Fesoterodine fumarate | 13 | 364 | £31 | -67.0% ▼ |
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 13 | 312 | £1.1K | +30.9% ▲ |
| Azelastine hydrochloride | 13 | 104 | £79 | +9.4% ▲ |
| Dorzolamide | 13 | 130 | £79 | -84.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.